Study | Administrative region (location) | Type of study | Type of participants | N° of participants | Methods of data collection & screening | Previous screening exposure | Screening uptake | Post-screening treatment | Follow-up |
---|---|---|---|---|---|---|---|---|---|
B. Wabo et al. 2019 [30] | Centre region (YUTH, YGOPH) | Cross-sectional study | Women (25–65 years) | 523 women | Questionnaires No screening | 209/523 (40%) | N/A | N/A | N/A |
J.S. Dohbit et al. 2018 [31] | Far North region (seven hospitals with maternity unit in Maroua) | Cross-sectional study | Post-partum women (25–45 years) | 622 women | Questionnaires No screening | 16/622 (2.6%) | N/A | N/A | N/A |
J.F. Domgue et al. 2020 [25] | North-west region (Seven remote villages) | Community intervention | Non-pregnant women (30–65 years) | 1292 women | Case forms Screening (self-HPV, VIA/VILI-DC in HPV -positive) | 60/1292 (4.7%) | 1270/1292 (98.3%) | Thermal ablation (161/182 = 88.5%) LEEP (1/1) | - Women treated with thermal ablation to follow-up > 1 year |
L. Donatus et al. 2019 [16] | North-west region (Kumbo-west HD) | Cross-sectional study | Women 25–65 years | 253 women | Questionnaires No screening | 110/253 (43.48%) | N/A | N/A | N/A |
G.E. Halle-Ekane et al. 2018 [29] | South-west region (University of Buea) | Cross-sectional study | Male & female students > 16 years | 416 students (208 males, 208 females) | Questionnaires No screening | 10/208 (4.8% did Pap smear) | N/A | N/A | N/A |
A. Adedimeji et al. 2021 [23] | South-west region (Limbe Regional Hospital) | Qualitative study | Women (≥ 25 years) and men | 80 women 20 men | 08 FGDs 08 IDI Screening (HPV-self collection) | None (due to inclusion criteria) | N/A | N/A | N/A |
A. Tassang et al. 2020 [21] | South-west (Buea Regional Hospital Annex) | Cross-sectional study (Intervention) | Women ≥ 21 years | 140 women | Questionnaire Screening (VIA/VILI-colposcopy) | 37/124 (29.8%) | 124/140 (88.6%) | Thermocoagulation (0/1 treated) LEEP (1/1 treated) | Follow-up for negative cases after 03 years |
C. Eakin et al. 2018 [19] | South-west region (University of Buea) | Cross-sectional study (Intervention) | Women ≥ 21 years (faculty, staff and students) | 120 women | Questionnaires Screening (VIA/VILI) | 39/120 (32.5%) | 115/120 (95.8%) | Thermocoagulation (5/5) LEEP (2/2 received) | - Low-grade lesions in 21–24 years to repeat screening > 1 year |
P.M. Tebeu et al. 2020 [24] | West region (health facilities in Mifi HD) | Cross-sectional study | HCPs (MD, nurses, midwives) | 200 HCPs | Questionnaires No screening | N/A | N/A | N/A | N/A |
M. Pham et al. 2022 [33] & P. Hämmerli et al. 2022 [32] & J. Levy et al. 2020 [28] & A.M. Datchoua et al. 2021 [22] & A.N. Roux et al. 2021 [17] | West region (Dschang HD) | Community intervention | Women 30–49 years | 1940 women in Dschang or surroundings | Questionnaires Screening (selfHPV, VIA/VILI in HPV +) | N/A | 100% | - Thermal ablation - LLETZ/LEEP | N/A |
Qualitative study | CHW aged 21–77 years | 11 CHWs | 11 IDI | N/A | N/A | N/A | N/A | ||
Community intervention | Women 30–49 years | 840 women | Case report forms Screening (self-HPV, VIA/VILI in HPV + women | N/A | 100% | - Thermal ablation (100%) - LEEP | After 5 years if HPV- After 1 year if HPV + & VIA/VILI - After 1 & 6 months if treated | ||
Qualitative study | Women 30–49 years and men | 31 women 12 men | 6 FGD Screening (self-HPV) | N/A | N/A | N/A | N/A | ||
West region (Dschang & Mbouda HD) | Qualitative study | HCP working in Dschang & Mbouda | 16 HCPs | 04 FGD Questionnaires | N/A | N/A | N/A | N/A | |
West region (Dschang HD) | Community intervention | Women 30–49 years | 1012 women | Data collection forms Screening (self-HPV, VIA/VILI) | N/A | HPV-100% VIA/VILI in 98.9% of HPV + | - Thermal coagulation | Repeat screening > 5 years if HPV neg –Control > 1 month if treated | |
R.T. Simo et al. 2021 [18] | West region (Djeleng & King Palace centres) | Intervention | Asymptomatic women (23–60 years) | 228 women | Questionnaires Screening (Pap smear) | 4/228 (1.75%) | 182/228 (79.8%) | N/A | N/A |
P. Cholli et al. 2017 [34] | South-west & Littoral(Mutengene & Mboppi Baptist hospitals) | Prospective (Intervention) | Women ≥ 30 years | 1170 women | Questionnaires Screening(clinician HPV & VIA/VILI-DC co-testing) | N/A | 100% | - Thermal ablation, LEEP - Cryotherapy Total: 18/44 | Participants’ phone numbers collected |
07 CBCHS WHP hospitals (multiregional) | Retrospective study (2007–2014) | HIV + women ≥ 21 years HIV-negative if ≥ 25 years | 44 979 women | Medical history Screening (VIA/VILI-DC) | N/A | 44 979/46 048 (97.7%) | - Same-day cryotherapy – 219/705(31.1%) - LEEP-unknown | VIA/VILI inadequate advised to return after one year for follow-up |